PDCD1 and central nervous system cancer: We have previously demonstrated the efficacy of the combination of 4-1BB agonism and anti-programmed cell death protein 1 (PD-1) checkpoint blockade (αPD-1/4-1BB) in a murine CT2A glioma model.